 CAMBRIDGE, Mass., June 16, 2021 GLOBE NEWSWIRE -- Sigilon Therapeutics, Inc. NASDAQ:SGTX, a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living TherapeuticsTM platform, today announced the appointment of Brooke Story to its Board of Directors. 